Medical Oncology

Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation
pp. 1-9(9)
Authors: Andersson, U.; Grankvist, K.; Bergenheim, A.; Behnam-Motlagh, P.; Hedman, H.; Henriksson, R.

Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer
pp. 11-14(4)
Authors: Miyata, Junya; Sano, Takahiro; Bando, Hiroyasu

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer
pp. 15-23(9)
Authors: Tulbah, Asma; Ibrahim, Ezzeldin; Ezzat, Adnan; Ajarim, Dahish; Rahal, Mohammed; Weshi, Amr; Sorbris, Ralph

Effect of topotecan infusion duration on hematologic toxicity in recurrent ovarian carcinoma
pp. 25-33(9)
Authors: Puls, Larry; Hunter, James; Crane, Martin

Treatment of malignant endocrine pancreatic tumors with a combination of α-interferon and somatostatin analogs
pp. 35-42(8)
Authors: Fjällskog, M.-L.; Sundin, A.; Westlin, J.-E.; Öberg, K.; Janson, E.; Eriksson, B.

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: Efficacy of therapy and value of serum tumor markers
pp. 43-53(11)
Authors: Schulze-Bergkamen, Henning; Zuna, Ivan; Teufel, Andreas; Stremmel, Wolfgang; Rudi, Jochen

Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma
pp. 55-58(4)
Authors: Avilés, Agustin; Neri, Natividad; Castañeda, Claudia; Talavera, Alejandra; Huerta-Guzmán, Judith; González, Martha

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia
pp. 59-67(9)
Authors: Üstün, C.; Beksac, M.; Dalva, K.; Koc, H.; Konuk, N.; Ilhan, O.; Özcan, M.; Topcuoglu, P.; Sertkaya, D.; Hayran, M.

Long-standing resolution of anemia in symptomatic low-grade non-hodgkin's lymphoma patients treated with recombinant human erythropoietin as sole therapy
pp. 69-72(4)
Author: Samuelsson, Jan